A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...

It also suppresses appetite and boosts feelings of fullness, which can then lead to reduced food intake and potential weight loss ... time. There are potential long-term side effects of semaglutide.

The increase in weight loss ... week time point in its pivotal trial. Martin Holst Lange, Novo Nordisk's head of development, said that the safety and tolerability of the two doses of semaglutide ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...

Bev battled health issues, including sleep apnoea and depression, and believed she was half-a-stone away from being ...

HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.

The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...